Monitoring of post‐transplant CBFB‐MYH11 as minimal residual disease, rather than KIT mutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia
Fei‐Fei Tang; Lan‐Ping Xu; Xiao‐Hui Zhang; Huan Chen; Yu‐Hong Chen; Wei Han; Yu Wang; Chen‐Hua Yan; Yu‐Qian Sun; Xiao‐Dong Mo; Kai‐Yan Liu; Xiao‐Jun Huang
Author Information: Peking University People's Hospital Peking University Institute of Haematology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.